Medicine that Causes Memory Loss: Risk of Neurocognitive Disorders
Journal Title: International Neuropsychiatric Disease Journal - Year 2016, Vol 8, Issue 1
Abstract
Medicine is one of the outstanding gifts of science to save lives. In addition to the desired therapeutic effect almost all of the medicine possesses the undesired secondary effect called side effect. From the over-the-counter (OTC) aspirin to the prescription medicine on the market, all medicines come with side effects. Numerous are negligible, few are problematic, some are major and certain are just weird. Almost any drug can cause nausea, vomiting or an upset stomach. Every medication carries some risks, although in some cases side effects are not noticeable as a result of sub-therapeutic concentration and memory loss are very common side effect of commonly used and prescribed medicines. The memory loss is one of the prominent causes of neurocognitive disorders, especially dementia, which is characterized by a disturbance of multiple brain functions, including memory, thinking, learning, reading calculation and judgment severe enough to reduce a person's ability to perform everyday activities. In addition to memory loss various factors as well as disorders contribute to the development of dementia. Alzheimer’s disease (AD) is the most common form of neurodegenerative dementia. Including AD, Lewy body dementia and frontotemporal dementia give rise to progressive and irreversible loss of neurons and brain functions. At present, there are no treatments for these progressive neurodegenerative disorders. Medication associated with the risk of memory loss must be taken with more precaution. Therefore, the objective of this study is to show the risk of memory loss associated with antianxiety drugs (benzodiazepines), hypolipidemic drugs (statins), antiepileptic drugs (older and newer), antidepressant drugs (tricyclic antidepressants), narcotic painkillers (opioids), anti-Parkinson's drugs (dopamine agonists), antihypertension drugs (β-blockers), sleeping aids (nonbenzodiazepine sedative-hypnotics), incontinence drugs (anticholinergics and antimuscarinic) and antihistamines (first-generation).
Authors and Affiliations
Md. Sahab Uddin, Abdullah Al Mamun, Nilufa Haque Chaity, Anamul Haque, Nahia Akter
Keywords
Related Articles
- EP ID EP241745
- DOI 10.9734/INDJ/2016/26317
- Views 141
- Downloads 0
A General Assessment of the Functional Impact of Acute Disseminated Encephalomyelitis
Introduction: Long-term disability in patients with acute disseminated encephalomyelitis (ADEM) is caused not only by neurological deficiency, but also by the difficulties with social and psychological adaptation. Togeth...
Can Glycosylated Hemoglobin and C-reactive Protein Levels Predict Development of Subclinical Neuropathy in Pre-diabetics?
Background: Individuals with elevated glycosylated hemoglobin (HbA1c) have a higher rate of microvascular complications, especially peripheral neuropathy. Objective: To find the relation between elevated (HbA1c) an...
Depression and Disability in Chronic Kidney Disease in Nigeria: A Case-Control Study
Aim: The main purpose of this study was to determine the prevalence of depression and disability in Chronic Kidney Disease (CKD) patients and to determine any association between stage of CKD and depression in the Univer...
The Spectrum of Herpesvirus Infections of the Nervous System in Adult Patients in Ukraine: A Prospective Single Center Study
Background: Herpesviruses (HVs) are ubiquitous pathogens that infect humans usually during childhood, followed by a life-long persistence in a latent state in many sites of a body including the nerve cells. After reactiv...
A Facility-based Assessment of Internalized Stigma among Patients with Severe Mental Illnesses in Maiduguri, North-Eastern Nigeria
Introduction: Public stigmatization of mental illnesses might lead to the internalization of the stigma by persons with mental illness (PWMIs) which might also lead to erosion of self-esteem and negative consequences on...